ライフサイエンスコーパス: marketing

1 game theory (auctions), and social networks (marketing).

2 ssue for research, nutritional labelling and marketing.

3 rove living standards, and enhance livestock marketing.

4 as where ranking has a role, from science to marketing.

5 mbine several policy tools and strong social marketing.

6 tritional quality of EVOOs and improve their marketing.

7 d Drug Administration over its first year of marketing.

8 e and during their respective first years of marketing.

9 blic health, law enforcement, and commercial marketing.

10 youngest legal targets for tobacco industry marketing.

11 oliferation of related terms used in product marketing.

12 ting authorization and, in some cases, after marketing.

13 used to inform protected area management and marketing.

14 es on cooking and experts in advertising and marketing.

15 ay offer a partial view of exposed off-label marketing.

16 on physicians and traditional pharmaceutical marketing.

17 education, financial modeling, policing, and marketing.

18 s of policies that address affordability and marketing.

19 pathways do not exist to guide research and marketing.

20 employees relative to the Prescription Drug Marketing Act or the False Claims Act and probationary s

21 ty to one violation of the Prescription Drug Marketing Act, settled claims related to alleged violati

22 his study are relevant for understanding how marketing actions can affect consumer choice behavior as

23 e paper provides evidence for the ability of marketing actions to modulate neural correlates of exper

24 We propose that marketing actions, such as changes in the price of a pro

25 leblower complaints as involved in off-label marketing activities adequately disclosed their conflict

26 em was an important driving factor for these marketing activities, Medicare has shifted to an Average

27 ts in the US alleged multifaceted and covert marketing activities.

28 using community-based distributers as social marketing agents and incorporating financing systems to

29 Billions of dollars are spent annually marketing alcohol.

30 Despite the importance and pervasiveness of marketing, almost nothing is known about the neural mech

31 und 46 was halted due to the contemporaneous marketing and clinical withdrawal of other centrally act

32 evelopment, and creating efficiencies in the marketing and distribution of educational materials and

33 , we evaluated the effect of community-based marketing and distribution of Sprinkles MNP on childhood

34 t Corporation withdrew the Ancure graft from marketing and distribution.

35 ve proven immensely useful in fields such as marketing and earth sciences, public health is still rel

36 on, such as fear and distrust; and different marketing and education strategies.

37 mong them law enforcement investigations and marketing and fundraising by health care organizations.

38 eness, it has the potential to delay product marketing and impede innovation.

39 osition, botanical aspects, pharmacological, marketing and nutrition of these species based on studie

40 insurance industry and reducing spending for marketing and other satellite services.

41 r advertisements; prohibiting youth-oriented marketing and sales; prohibiting child-friendly ENDS fla

42 ributed in part to the perception created by marketing and the popular press that they are safer than

43 clinical and regulatory decisions about the marketing and use of new treatments, these assumptions m

44 cognitive neuroscience, in the realm of law, marketing, and beyond.

45 lth, clinical science, economics, sociology, marketing, and genetics, and for combining individual ch

46 tems engineering, organizational management, marketing, and health education were identified.

47 ical considerations involving public health, marketing, and nutrition education have stimulated inter

48 es in the areas of psychological assessment, marketing, and privacy.

49 cco products; regulation of the advertising, marketing, and promotion of tobacco products; regulation

50 access to resources for program development, marketing, and resource allocation.

51 the dense built environment, pervasive food marketing, and the increased availability of energy-dens

52 al basis for 68% (39 of 57) of oncology drug marketing applications granted regular approval and for

53 social science, social media analytics, and marketing applications.

54 n of failed applications is costly, delaying marketing approval and the availability of new drugs to

55 Finally, some important barriers to marketing approval are described.

56 In a study reported herein, the marketing approval dates of 214 drugs newly introduced i

57 ugs received US Food and Drug Administration marketing approval for acute myeloid leukemia (AML) trea

58 er regular marketing approval or accelerated marketing approval for oncology drug applications.

59 inistration (FDA) under a system that grants marketing approval for only those indications for which

60 t thrombin inhibitor dabigatran has received marketing approval from the European Medicines Agency.

61 To overcome this, the FDA may grant marketing approval of a new product based upon the "Anim

62 rocesses that supported drug development and marketing approval of DAAs for treatment of hepatitis C,

63 Evidentiary standards for marketing approval of drugs, biologicals, and devices ge

64 The FDA grants either regular marketing approval or accelerated marketing approval for

65 The FDA granted marketing approval to 71 oncology drug applications betw

66 gh-risk therapeutic devices received initial marketing approval via the PMA pathway.

67 f an anticancer agent at the time of initial marketing approval, sponsors customarily collect compreh

68 re gaining U.S. Food and Drug Administration marketing approval.

69 on and sale of these data for pharmaceutical marketing are currently the subjects of legislation in s

70 cipants rated scenarios in which the use was marketing as less appropriate than when the use was rese

71 o establish a monopoly, it planned intensive marketing, as if in a competitive market, aiming to targ

72 s of clinical investigation or have received marketing authorisation for adults; however, none have d

73 industry-oriented protocols before granting marketing authorisation.

74 th drug development and are refined prior to marketing authorization and, in some cases, after market

75 United States marketing authorization for one drug, gefitinib (an epid

76 ucing country, then prequalified and given a marketing authorization in the user countries.

77 needed before considering a revision of the marketing authorization process for antibacterial generi

78 driving basic immunological research and for marketing authorization purposes by regulatory authoriti

79 nt phenolic antioxidant from rosemary with a marketing authorization, spontaneously forms a relativel

80 ffectiveness of interventions addressing the marketing, availability, and price of healthy and unheal

81 Policies focus on price, marketing, availability, information and education, the

82 iopolitical factors, such as tobacco-related marketing bans and higher cigarette taxes.

83 y illustrates the relative importance of the marketing based benefits that accrue to Leadership in En

84 riven by both performance-based benefits and marketing based benefits.

85 Marketing benefits due to LEED certification drives orga

86 Marketing benefits stem from the consumer response to gr

87 ipants in the LEED certification scheme seek marketing benefits.

88 The second is the marketing between December 1995 and April 1997 of 4 huma

89 oS displays will prevent this means of price marketing but our study also suggests that minimum prici

90 ed during the first two years of natalizumab marketing but, by the end of November, 2009, 28 cases ha

91 Research and scholarship were also used for marketing by encouraging "key customers" to participate

92 eight loss centers or for direct-to-consumer marketing by manufacturers and does not apply to patient

93 concerns, and it has never been approved for marketing by the FDA.

94 e approach to prevention is a Vermont social marketing campaign that encouraged sexual offenders to s

95 pragmatic use and validation, we carry out a marketing campaign that shows a threefold increase in re

96 However, aggressive-marketing campaigns and lack of regulation of hospital w

97 t from the support of educational and social marketing campaigns developed with governmental input an

98 Marketing campaigns directed at both physicians and pati

99 Efforts to counter tobacco marketing campaigns should include people of all ages, p

100 wer testimony have alleged complex off-label marketing campaigns that remain concealed to company out

101 bacco products, smoke-free policies, counter-marketing campaigns, advertising restrictions, augmentin

102 rs, as tobacco companies continue aggressive marketing campaigns.

103 Social marketing can be applied to medical education in the eff

104 Pharmaceutical marketing can lead to overdiagnosis, overtreatment, and

105 ry hurdles, which might prevent vendors from marketing cardiac MR perfusion imaging, may have hampere

106 ns of median price per ounce on the basis of marketing claims (eg, dermatologist recommended, fragran

107 However, an examination of Internet-based marketing claims revealed widespread promotion of such i

108 Pre-marketing clinical studies of tegaserod suggested an inc

109 ite businesses, such as consulting firms and marketing companies, consume an increasing fraction of t

110 ovement in the transparency of local seafood marketing compared to previous studies, the results rema

111 Agronomic and marketing considerations must be carefully evaluated whe

112 s that pass along research, development, and marketing costs to the consumer; providers of cancer car

113 ns of neuroscience to such diverse arenas as marketing, criminal justice, the military, and worker pr

114 division handled both the scientific and the marketing data, including collection, analysis, and diss

115 (InfoGroup, Papillion, Nebraska) commercial marketing database for neighborhood control recruitment

116 idential telephone numbers from a commercial marketing database.

117 for human health and the environment and/or marketing decisions by the manufacturers, and changes in

118 them in domains as diverse as epidemiology, marketing, development economics, and public health.

119 on to fulfill a marketing objective; Merck's marketing division handled both the scientific and the m

120 ey themes: The trial was designed by Merck's marketing division to fulfill a marketing objective; Mer

121 AGE was a seeding trial developed by Merck's marketing division to promote prescription of Vioxx (rof

122 he recent surge in direct-to-consumer device marketing, do-it-yourself enthusiasm, and an escalating

123 analyzed previously secret tobacco-industry marketing documents.

124 T patients, there is variability in the post-marketing dosing of regorafenib.

125 re immediate product-driven research or even marketing dressed up as research.

126 ent data sources can be used to augment post-marketing drug safety signal detection.

127 European Union law prohibits companies from marketing drugs off-label.

128 For decades methodologists in psychology, marketing, education, and survey research have studied t

129 apers, documents were found describing Merck marketing employees developing plans for manuscripts, co

130 Schools present highly desirable marketing environments for food and beverage companies.

131 iding an incentive in the form of additional marketing exclusivity.

132 ve, randomized clinical trials and from post-marketing experience.

133 The tremendous potential of social marketing for medical education should be pilot-tested a

134 ut the appropriateness of direct-to-consumer marketing for oncologic medications.

135 43 (Viracept) has recently been approved for marketing for the treatment of AIDS.

136 idence shows that ADVANTAGE is an example of marketing framed as science.

137 blower complaints alleging illegal off-label marketing from the US Department of Justice and other pu

138 However, the techniques of social marketing-goal identification, audience segmentation, an

139 Thus, because tobacco cessation product marketing has been altered as a result of these financia

140 d patients has been widespread, but how this marketing has contributed to the diffusion of the techno

141 It has been suggested that pharmaceutical marketing has influenced these prescribing patterns.

142 Tobacco-industry marketing has played a central part in the global spread

143 edit, supply-chain strengthening, and social marketing have been ignored.

144 d exposure to environmental cues (e.g., food marketing); however, the mechanisms that link these fact

145 The Zenith received approval for marketing in 2003 and has gained relatively wide use, in

146 Soon after initial marketing in March 1997, troglitazone, the first thiazol

147 ry and only two contained elements of social marketing in the design, although five addressed sustain

148 In 2001, alemtuzumab was approved for marketing in the United States and Europe for use in pat

149 ber of new antibiotics annually approved for marketing in the United States continues to decline.

150 r and ritonavir were approved by the FDA for marketing in the USA), to August, 1996, 14 (29%) of 49 p

151 Time from drug discovery to marketing increased from 8 years in 1960 to 12 to 15 yea

152 ersight, taxation, flavorings, promotion and marketing, indoor and public use, and research.

153 cal acceptability of interactions; perceived marketing influence; perceived reliability of industry i

154 n education and provides some assurance that marketing information is accurate.

155 its collected and the use of recruitment and marketing initiatives that appeal to the increasingly di

156 Sponsors have a marketing interest to represent their products in the be

157 ntervention stores received a 6-mo, in-store marketing intervention that promoted the sales of health

158 gineering junk food to make it addictive and marketing it to young children.

159 However, the rapidly changing food-marketing landscape requires research to measure the eff

160 promotion of safe behaviours through social marketing, legislation, and law enforcement.

161 These include polling, marketing, management, insurance, and public health prog

162 decline although cessation of alpha-blocker marketing may have hastened the decline.

163 on physician-industry interactions, industry marketing may target other health professionals.

164 ood policies are warranted to support social marketing messages and to reduce the cultural and econom

165 or reaching physicians, allowing delivery of marketing messages at the point of care, when clinical d

166 consumption trends consistent with industry marketing models would be expected to increase the impac

167 ), school-based programs (n = 2), and social marketing (n = 2) (2 interventions tested multiple appro

168 alysis, and dissemination; and Merck hid the marketing nature of the trial from participants, physici

169 d by Merck's marketing division to fulfill a marketing objective; Merck's marketing division handled

170 a scientific question but primarily fulfill marketing objectives, have not been described in detail.

171 urers, and changes in cultural practices and marketing objectives.

172 artnership with industry will accelerate the marketing of a male hormonal contraceptive.

173 The marketing of breastmilk substitutes negatively affects b

174 rt has been expended to restrict the adverse marketing of breastmilk substitutes, similar effort now

175 omparison was also made to the first year of marketing of cerivastatin.

176 However, successful marketing of complement-targeted drugs has proved to be

177 tensivists to remain in the field, proactive marketing of critical care, and expanded engagement by t

178 nce required for regulatory approval for the marketing of drugs and biologics when only a single pivo

179 tine method to avoid the mislabelling in the marketing of Genypterus species.

180 ssociated with screening, direct-to-consumer marketing of helical CT is not advisable.

181 One alternative explanation is that the marketing of high-sugar foods, especially sugar-sweetene

182 fruit which often results in harvesting and marketing of inedible, immature or over ripe berries.

183 necessary to reduce exposure of children to marketing of less healthful foods.

184 ciated with the development, production, and marketing of new drugs and technologies, many of which a

185 f Spain) wants to promote the production and marketing of new sweet wines.

186 Galicia, wants to promote the production and marketing of new sweets wines.

187 caffolds has resulted in the development and marketing of over 100 antibacterial agents but, with the

188 d inform the development, manufacturing, and marketing of pediatric medications for resource-limited

189 conflict of interest in the development and marketing of pharmaceutical products.

190 generation of transgenic plant lines to the marketing of purified proteins.

191 der children from increasingly sophisticated marketing of sedentary activities and energy-dense, nutr

192 in the absence of medical necessity and the marketing of soy products designed to appeal to children

193 eir availability in schools; restrictions on marketing of sugary foods to children; public awareness

194 tnership have challenged the development and marketing of telavancin.

195 h the Food and Drug Administration to permit marketing of the code.

196 nhibitors has resulted in an increase in the marketing of the drugs.

197 rooms is an obstacle to the distribution and marketing of the fresh product.

198 were the major cause for discontinuation of marketing of these antibiotics.

199 of recommendations aimed at restricting the marketing of tobacco products.

200 g tobacco industry influence on taxation and marketing of tobacco; we included 45 of 46 papers in the

201 Direct-to-consumer marketing of unapproved stem cell interventions is a wel

202 oduce legislation to restrict the commercial marketing of unhealthy foods and beverages to children.W

203 odel to underpin regulations restricting the marketing of unhealthy foods to children.

204 excluded unless the testimonial appeared as marketing on a commercial site.

205 asure the effects of nontraditional forms of marketing on the health-related behaviors of children.

206 do not require clinical studies before their marketing or formal approval from regulatory agencies, a

207 that most medicines that were withdrawn from marketing or received a black-box warning because of hep

208 (FAERS) remains the primary source for post-marketing pharmacovigilance.

209 ted products but might be helpful from their marketing point-of-view.

210 PPD limits cassava's marketing possibilities in countries that are undergoing

211 rtainty than banking for allogeneic use; (4) marketing practices for UCB banking in the private secto

212 nd state investigations of allegedly illegal marketing practices of other pharmaceutical firms and ha

213 ng countries by teaching basic financial and marketing practices, yet the impacts of such programs ar

214 and may not represent a complete picture of marketing practices.

215 It is important to systematically test marketing principles to determine which techniques are e

216 ng") is a practical implementation of social marketing principles to improve antibiotic use.

217 ollect double red blood cell units; targeted marketing programs to provide effective messages; season

218 ure on tobacco industry efforts to influence marketing regulations and develops taxonomies of 1) indu

219 nce to tobacco industry efforts to influence marketing regulations; supported claims with verifiable

220 an injectable clinical biomaterial must meet marketing, regulatory, and financial constraints to prov

221 ng ultrasound contrast agents following post-marketing reports of 4 patient deaths that were temporal

222 (gift policies, r = 0.28, 95% CI 0.11-0.44; marketing representative access policies, r = 0.51, 95%

223 0.19-1.04) and less likely to interact with marketing representatives (AMSA score, OR 0.33, 95% CI 0

224 students' gift acceptance, interactions with marketing representatives, and perceived adequacy of fac

225 eceived gifts and having not interacted with marketing representatives.

226 lacement therapy (PERT) to have approval for marketing, rescinding the distribution of PERT that had

227 control efforts by applying tobacco-industry marketing research and strategies to clinical and public

228 ethods from operation risk index analysis in marketing research to develop a formula that considers a

229 overnment have instituted self-regulation of marketing, research in the psychology and social science

230 een nutrient profile (NP) models relevant to marketing restrictions by applying them in the Canadian

231 ncreases, 14% by smoke-free air laws, 14% by marketing restrictions, 8% by health warnings, 6% by mas

232 , smoke-free air laws, mass media campaigns, marketing restrictions, packaging requirements, cessatio

233 vary greatly between NP models applicable to marketing restrictions.

234 ss authorized the FDA to grant extensions of marketing rights known as "pediatric exclusivity" if FDA

235 tration (FDA) to grant 6-month extensions of marketing rights through the Pediatric Exclusivity Progr

236 are tasked with supervising compliance with marketing rules.

237 the production, shipment, storage, and post-marketing safety of generic oncology drugs.

238 adverse drug reactions are important to post-marketing safety surveillance worldwide.

239 tion are needed to prevent the inappropriate marketing, sale, and clinical use of unlicensed botulinu

240 e apparent strategic goals of each off-label marketing scheme and the practices consistent with those

241 e findings are consistent with the idea that marketing self-regulation has failed to keep television

242 on-level cohort study using Intercontinental Marketing Services Health Canada's data from June 2003 t

243 eloped world will need the manufacturing and marketing skills of the pharmaceutical industry.

244 Encouraged by direct-to-consumer marketing, smokers and their physicians are contemplatin

245 ng their financial interests) such as social marketing, social franchising, vouchers, and contracting

246 ethylene pathway, and innovative storage and marketing solutions for current and novel fruit cultivar

247 Marketing strategies and tactics were identified by usin

248 and using more sophisticated recruitment and marketing strategies as well as automated collection tec

249 Marketing strategies ensure that the products are promot

250 research on this topic has mainly focused on marketing strategies for garnering public acceptance of

251 o promotion, and discuss the use of targeted marketing strategies in the UK.

252 In-store marketing strategies that draw attention to healthier pr

253 veness of utilizing personalized direct-mail marketing strategies to promote organ donation with an e

254 Few controlled studies of in-store marketing strategies to promote sales of healthier items

255 tudy was to evaluate the effects of in-store marketing strategies to promote the purchase of specific

256 argely due to sophisticated and manipulative marketing strategies.

257 -the present campaign employed a direct-mail marketing strategy that registered 6908 individuals in t

258 ing With Emboli Protection Surveillance-Post-Marketing Study [CASES-PMS]; NCT00231231).

259 ing With Emboli Protection Surveillance-Post-Marketing Study) multicenter, prospective, single-arm, s

260 ve measurement of adoption to inform design, marketing, subsidies, finance, or dissemination practice

261 pproach that utilizes clinical SEs from post-marketing surveillance and the drug label to predict 1,5

262 EGF agents will only be achieved though post-marketing surveillance or through the interrogation of h

263 m, and Aging Medical Information System Post-Marketing Surveillance Program cohort, involving 4,258 c

264 The objective of the Olestra Post-Marketing Surveillance Study was to examine whether cust

265 In a non-interventional, observational, post-marketing surveillance study, patients with an establish

266 ed with trends on clinical outcomes and post-marketing surveillance to assess safety, serve as the fo

267 ogenetic maps for drug registration and post-marketing surveillance will result in safer, more effect

268 ents in the ongoing outcome studies and post-marketing surveillance.

269 either during regulatory testing or in post-marketing surveillance.

270 Changes to these device approval and post-marketing systems must be accompanied by ongoing researc

271 Tobacco marketing targets smokers of all ages; young adults are

272 Marketing techniques have been very effective in changin

273 s have FCOIs with the pharmaceutical company marketing that drug.

274 dronic acid received regulatory approval for marketing, the FDA received reports of nine patients wit

275 Although these initiatives need improved marketing, the Society of Critical Care Medicine members

276 They are still aggressively marketing their products to teenagers, ethnic minority g

277 In marketing these foods, manufacturers may come under one

278 st half of prepackaged foods as eligible for marketing to children [49.0% (95% CI: 48.2%, 49.8%)].

279 oportion of foods that would be eligible for marketing to children was calculated with the use of eac

280 ood companies' stated intentions to increase marketing to Hispanics.

281 Marketing to physicians, hospitals, and patients has bee

282 ears, despite the industry's intent to avoid marketing to underage persons.

283 communities in rural Bangladesh to different marketing treatments-community motivation and informatio

284 he introduction of LOCM but did not consider marketing trends or secular reporting trends.

285 Mean ratings ranged from a low of 3.81 for a marketing use when consent was not obtained and specific

286 ere rated as more appropriate than consented marketing uses (5.65 vs. 4.52; difference, 1.13 [CI, 0.8

287 The UK self-regulatory system for exposing marketing violations relies largely on complaints from c

288 Social marketing was used to create awareness and generate dema

289 d and a pharmaceutical company used data for marketing (weighted mean appropriateness, 2.7).

290 tatin-associated AERs over its first year of marketing were compared with those seen with atorvastati

291 Combining social marketing with community-based distribution provides an

292 th Food and Drug Administration approval for marketing - Y(90) ibritumomab tiuxetan and I(131) tositu